461 results on '"Arts, Eric J."'
Search Results
2. Real-time evaluation of signal accuracy in wastewater surveillance of pathogens with high rates of mutation
3. G-Quadruplex DNA and Other Non-Canonical B-Form DNA Motifs Influence Productive and Latent HIV-1 Integration and Reactivation Potential
4. Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans
5. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles
6. Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants
7. Viral disinfection using nonthermal plasma: A critical review and perspectives on the plasma-catalysis system
8. Dolutegravir response in antiretroviral therapy naïve and experienced patients with M184V/I: Impact in low-and middle-income settings
9. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection
10. Genomic Surveillance of a Canadian Airport Wastewater Samples Allows Early Detection of Emerging SARS-CoV-2 Lineages
11. Effective and targeted latency reversal in CD4 + T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection
12. Addressing an HIV cure in LMIC
13. Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance
14. HIV-1 Entry and Fusion Inhibitors: Mechanisms and Resistance
15. A Dual Loci Quality Assurance and Control Framework for Real-Time Evaluation of Signal Accuracy in Wastewater Surveillance of Pathogens with High Rates of Mutation
16. An in vitro Model to Mimic Selection of Replication-Competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients
17. To find one of Ontario's big pandemic wins, just look down your toilet
18. Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV
19. Per-pathogen virulence of HIV-1 subtypes A, C and D
20. Initiation of (-) Strand DNA Synthesis from tRNA$_{3}^{\text{Lys}}$ on Lentiviral RNAs: Implications of Specific HIV-1 RNA-tRNA$_{3}^{\text{Lys}}$ Interactions Inhibiting Primer Utilization by Retroviral Reverse Transcriptases
21. Pathogenic infection of Rhesus macaques by an evolving SIV-HIV derived from CCR5-using envelope genes of acute HIV-1 infections
22. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa
23. First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda
24. The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030
25. Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses
26. Supplementary Material to 'Per-Pathogen Virulence of HIV-1 subtypes A, C and D' from Per-pathogen virulence of HIV-1 subtypes A, C and D
27. Correction: A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2
28. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates?
29. A cis-Acting Element in Retroviral Genomic RNA Links Gag-Pol Ribosomal Frameshifting to Selective Viral RNA Encapsidation
30. A hybrid stochastic–deterministic computational model accurately describes spatial dynamics and virus diffusion in HIV-1 growth competition assay
31. Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope
32. Monovalent and trivalent VSV-based COVID-19 vaccines elicit potent neutralizing antibodies and immunodominant CD8+ T cells against diverse SARS-CoV-2 variants
33. Early Warning Measurement of SARS-CoV-2 Variants of Concern in Wastewaters by Mass Spectrometry
34. A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
35. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease
36. Per-Pathogen Virulence of HIV-1 subtypes A, C and D
37. Monovalent and Trivalent VSV-Based COVID-19 Vaccines Elicit Potent Neutralizing Antibodies and Immunodominant CD8 + T Cells Against Diverse SARS-CoV-2 Variants
38. A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2
39. Mutated K65R Recombinant Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Shows Diminished Chain Termination in the Presence of 2',3'- Dideoxycytidine 5'-Triphosphate and Other Drugs
40. High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations
41. An Amino Acid Polymorphism within the HIV-1 Nef Dileucine Motif Functionally Uncouples Cell Surface CD4 and SERINC5 Downregulation
42. Is HIV-1 evolving to a less virulent form in humans?
43. From Simian to Human Immunodeficiency Viruses (SIV to HIV)
44. Contributors
45. Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period
46. Past, Present, and Future of Entry Inhibitors as HIV Microbicides
47. Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1
48. Calculating HIV-1 Infectious Titre Using a Virtual TCID50 Method
49. Elucidating the viral and host factors enabling the cross-species transmission of primate lentiviruses from simians to humans
50. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.